When it was first identified, B7-H6 was expressed in the tumor cells of patients with lymphoma and various cell lines, including T lymphoma, B lymphoma, myeloid leukemia, and melanoma, but it was rarely expressed in normal peripheral blood mononuclear cells [7,9]. Here, NCR3LG1 is linked to myeloid leukemia.